Using an immunocytochemical method, we examined the immunological responses of adult mice to intracerebellar syngeneic and allogeneic fetal mouse brainstem transplants (embryonic days 12-14). Syngeneic grafts and major histocompatibility complex (MHC)-compatible and non-MHCincompatible allogeneic grafts survived well, showing no histological signs of rejection even 6 months after transplantation, and with no expression of MHC antigens being observed in any of the grafts. However, most cases of both MHC-and non-MHCincompatible allografts showed rejection responses, such as marked neovascularization, cellular infiltration and necrosis, two weeks to one month after transplantation, In animals showing rejection, Class I MHC antigens were found on grafted neuronal tissue. An increased number of reactive astrocytes was also observed in the grafts. High levels of Class I antigen expression and prominent gliosis correlated with vigorous cellular infiltration. A quantitative analysis of T cell subsets in the animals showing rejection revealed that the L3T4/Lyt-2 ratio was 1.02 + 0.21 (mean + S.D.), indicating that helper/inducer and cytotoxic/suppressor T cells appeared equally in the rejection of MHC-and non-MHC-incompatible allografts. We consider that in these experiments, the brain was not completely an immunologically privileged site, and that MHC-and non-MHC-incompatible intraparenchymal neural transplants were not shielded from host immune surveillance.
Introduction
Neural transplantation into the central nervous system (CNS) has in recent years received considerable attention, especially in connection with attempts to ameliorate anatomical and physiological defects (Bj6rklund et al. 1979; Gash et al. 1980) and to treat Parkinson's disease (Backlund et al. 1985; Madrazo et al. 1987) . The brain has been considered to be an immunologically privileged site by virtue of the blood-brain barrier (Barker and Billingham 1977) and the poorly developed lymphatic drainage system (Bradbury and Westrop 1983) . However, this concept has recently been undergoing change, since rejection of histoincompatible neural grafts is these days commonly observed (Brundin et al. 1985; Inoue et al. 1985; Mason et al. 1986; Nicholas et al. 1987) .
In all animal species one genetic locus, the major histocompatibility complex (MHC), called HLA in humans and H-2 in mice, encodes for antigens capable of inducing strong allogeneic reactions. Thus, Class I and Class II transplantation antigens are gene products of the MHC locus. Although normal brain tissue has been reported to contain low levels of MHC antigens (Wong et al. 1984; Lampson 1987) , neural MHC expression is increased in neuropathologic conditions such as multiple sclerosis and Alzheimer's disease (Traugott et al. 1985; McGeer et al. 1987) . The role of MHC antigens in brain transplantation, however, has not been fully investigated.
T lymphocytes predominate and are thought to be the most important mediators of organ graft rejection (Hall et al. 1978 ). There have been many studies involving immunocytochemically identified cellular infiltrations in kidney allografts, using commercially available monoclonal antibodies (Hancock et al. 1983; Hall et al. 1984; van Es et al. 1984; Sanfilippo et al. 1985) . In studies into the rejection i6 
responses against brain allografls, however, such identification has not been satisfactorily achieved.
In the present study, we transplanted mouse brainstem primordia into the cerebellar vermis of adult mice in order to examine histologically the following points: 1) the relationship between immune responses and the MHC differences between donor and recipient, 2) MHC antigen expression of the grafted tissue, and 3) the T cell subpopulations.
Material and methods

Animals used (Table 1)
Highly inbred mice from the Mouse Colony of Okayama University were used for the present experiments. RF/J (H-2 k) mice were used as both donors and recipients, while C3H/He (H-2 k) and BALB/c (H-2 d) mice were used as recipients only. The RF/J and the C3H/He strains possess the same MHC but different non-MHC antigens, whereas BALB/c mice differ from RF/J mice at both the MHC and non-MHC loci. In the adult brain, RF/J mice express the Thy-l.1 cell surface antigen, whereas C3H/He and BALB/c mice express Thy-l.2. Thus, while RF/J Mice were used as donors in all experiments, the recipients were divided into three groups. Group A (n = 9) consisted of RF/J mice, thus receiving a syngeneic graft; Group B (n = 30) contained C3H/He mice, MHC-compatible and non-HMC-incompatible (in the following abbreviated to MHCcompatible) with the donor; Group C (n = 31) contained BALB/c mice, both MHC-and non-MHC-incompatible (in the following abbreviated to MHC-incompatible) with the donor.
Transplantation methods
In all experiments, brainstems dissected flee from fetuses (RF/J) on embryonic days 12-14 were transplanted into the vermal part of the cerebellum of adult mice. In this procedure a small piece (ca. 0.6 mm 3) of tissue was excised from the donor under a dissecting microscope in Eagle's minimal essential medium (Flow Lab, U.K.), and was loaded into a glass cannula with a tight fitting stainless steel plunger. For intraparenchymal grafting, the recipients were anesthetized and placed in a stereotaxic apparatus with the incisor bar set 3 mm below the interaural line. The cannula containing the graft was placed 7 mm posterior to the bregma in the midline, and was inserted to 3 mm below the brain surface. The graft was ejected from the cannula, which was then removed. All procedures were performed aseptically under a dissecting microscope.
Histological processing
Transplant-recipient mice were sacrificed under deep anesthesia at various stages after transplantation and their tissues processed for histological and immunocytochemical studies. Host cerebella were dissected out and frozen in Tissue Tek II OCT compound. Serial 8 ~m-thick sagittal sections were cut on a cryostat and mounted on gelatin-coated slide glasses. The sections were air-dried and fixed in cold acetone for 10 rain. After rinsing in 0.1 M phosphatebuffered saline (PBS), they were stained with monoclonal antibodies against Thy-l.1 antigen, Class I and Class II MHC antigens and T lymphocyte subsets, and with polyclonal antibody against glial fibrillary acidic protein (GFAP; BioGenex Lab, USA), according to the avidin-biotin-peroxidase complex (ABC) procedure (Hsu 1981) . Alternating series of sections were also stained by the NissI method and by Palmgren's silver method (Palmgren 1948) to visualize the nerve fiber architecture.
The monoclonal antibodies used were: anti-L3T4 antibody against helper/inducer T eeUs and anti-Lyt-2 antibody against cytotoxic/suppressor T cells (Sera Lab, U.K.), as well as anti-Thy-1.1 antibody, anti-H-2K k antibody against Class I antigens and anti-Ia k antibody against Class II antigens (Meiji Institute of Health Sciences, Japan).
For detection of L3T4-and Lyt-2-positive cells, sections were sequentially incubated with 20% horse serum, anti-L3T4 or antiLyt-2 antibodies diluted 1 : 50 in PBS, biotinylated rabbit anti-rat IgG (Vector Lab, USA) diluted 1 : 200 in PBS, and avidin-biotinperoxidase complex (Vector Lab, USA) diluted 1 : 50 in PBS. Each incubation was performed at room temperature and sections were washed in four changes of PBS. After the final wash, the sections were incubated with 0.05 % diaminobenzidine and 0.01% hydrogen peroxide in 50 mM Tris-buffered saline. For control sections, the primary antibodies were replaced with PBS.
For detection of Thy-l.1, Class I and Class II MHC antigens and of GFAP, sections were also immunostained according to the ABC procedures. Some immunostained sections were counterstained with hematoxylin or methyl green, dehydrated and coverslipped in Permount (Fisher Scientific Company, USA).
Results
Group A (syngeneic graft)
Nine syngeneic grafts were performed and the recipient mice were sacrificed one month after transplantation. All ,transplants survived well in the host cerebellum and there were no histological signs of rejection (see below). No expression of Class I or Class II MHC antigens was detected in any of the transplants. The transplants proved to have matured by their ability to express adult levels of Thy-l.1 antigen, showing that our fetal grafts differentiated in the host cerebellum.
Group B (MHC-compatible allograft)
Thirty mice were sacrificed one month (n = 11), three months (n = 10) or six months (n = 9) after transplantation. Healthy grafted tissues were 1A) . Expression of M H C antigens on the grafts was not observed in any of the experiments (Fig. 1B) . The grafts showed signs of maturation in that they uniformly expressed adult levels of Thy-1.1 antigen. It was also possible to distinguish between donor and host tissues by means of immunoperoxidase staining for Thy-l.1 antigen, because the host 17 (C3H/He) expressed the Thy-l.2 antigen (Fig. 1C) .
In the region where the white matter of the host cerebellum and the grafted tissue adjoined, nerve fibers which traversed between host and graft were observed by silver staining. These results indicated that the brainstem primordia were able to develop well when transplanted into the cerebella of MHCcompatible recipients.
Group C (MHC-incompatible allograft)
Thirty-one mice received transplants in this group, and were sacrificed one week (n = 9), two weeks (n = 10) and one month (n = 12) after transplantation. One week after grafting all grafts examined had survived and there were no signs of rejection. However, rejection responses such as marked neovascularization, cellular infiltration and necrosis were observed after two weeks in one animal (10%) and after one month in nine (75%) ( Fig. 2A) . In most cases the infiltrations formed cuffs of cells around blood vessels (Fig. 3C) . Thus, most fetal brainstems grafted from MHC-incompatible donors elicited host rejection responses by one month after transplantation. In such animals, expression of Class I MHC antigens was observed on the grafts, especially around blood vessels where cellular infiltrations were (Fig. 2B ). High levels of Class I antigen expression correlated with vigorous cell infiltrations. Thy-l.1 expression was patchy in heavily infiltrated cases, indicating that maturation of grafted neuronal tissue did not proceed normally. Table 2 summarizes the results obtained for the three experimental groups.
Gliosis
In both syngeneic and MHC-compatible allogeneic transplants, GFAP staining revealed that while gliosis occurred around the grafts' borders, only a few GFAP-positive cells appeared within the grafts (Fig. 3A, B) . Within MHC-incompatible allografts undergoing rejection, however, the number of GFAP-staining reactive astrocytes was considerably greater than those detected in syngeneic and MHCcompatible allogeneic grafts. Reactive astrocytes and cellular infiltrations occurred in close proximity (Fig. 3C, D) . MHC-incompatible allografts containing the heaviest cellular infiltrations also showed the most prominent gliosis, thus indicating a role for reactive astrocytes in the immune response.
T-lymphocyte subpopulations
In MHC-incompatible allografts undergoing rejection, infiltrations of T lymphocytes were prominent around blood vessels and near the borders of the grafts, and no clear differences in the infiltration patterns of the two T cell subsets were observed (Fig. 4A, B) . Stained T cells of each subset were counted in single 0.25 mm 2 areas of representative adjacent sections in each mouse, and a quantitative analysis of the results was made. The L3T4-positive cell count per 0.25 mm 2 was 196 + 74 (mean + S.D.), while that for Lyt-2-positive cells was 20 198 + 87, giving a L3T4/Lyt-2 ratio of 1.02 + 0.21. Thus, there was no statistically significant difference between the two counts. In syngeneic (n ---9) and MHC-compatible allogeneic (n = 30) grafts, T cell infiltration was not observed except in three allografts where the maximum T cell counts were only about 10 per 0.25 mm 2. In these three cases, signs of rejection such as neovascularization and necrosis were not noticeable.
Discussion
As neural transplantation work has focused primarily on the structural and functional aspects, issues of immunological problems have previously been of relatively little concern. However, because of its clinical application to Parkinson's disease (Backlund et al. 1985; Madrazo et al. 1987 ) and due to the use of fetal mesencephalic allogeneic transplantation for an animal model of Parkinson's disease (Bakay et al. 1987) , the problem of immunologic responses to neural allografts needs to be addressed in the same way that it does for other organ transplantations. Only recently, have some neural transplantation studies dealt with the immune responses elicited by brain grafts (Reif 1984; Geyer et al. 1985; Head and Griffin 1985) . Xenografts and allografts from genetically disparate donors were found to be rejected (Mason et al. 1986; Nicholas et al. 1987) , and immunosuppressive agents were shown to be effective in preventing rejection reaction against brain grafts (Brundin et al. 1985; Inoue et al. 1985; Str6mberg et al. 1986) . In this study, we performed syngeneic and allogeneic neural transplantations in mice, and examined the immunological reactions against the grafted tissue.
In our syngeneic grafts, no rejection responses were observed. The results were consistent with those obtained with other organ transplantations, showing that genetically compatible grafts did not incite immune responses (Myrvik and Weiser 1984) . Furthermore, MHC antigens were not expressed in our syngeneic grafts as far as examined at one month after transplantation. However, a transient weak expression of MHC might have been possible before the first month, e.g., within a week (Mason et al. 1986 ).
There were quite large differences between the results obtained for MHC-compatible allografts and those obtained for MHC-incompatible ones. In animals which received MHC-compatible allografts, no rejection responses were observed even 6 months after transplantation, and expression of MHC antigens was not detected on the graft. In those which received MHC-incompatible allografts, however, most (9/12, 75%) showed rejection reactions one month after grafting. Thus, provided the donor and host MHC loci were identical, rejection responses were not observed over a long period of time, even if the non-MHC loci were different. In our experiments, 25% (3/12) of MHC-incompatible allogeneic graft tissues escaped rejection responses, even in the absence of immunosuppressive treatment (see Table 2 ). Although the reason for the variability of survival and rejection of MHC-incompatible allografts is not clear, it may be due to variation of MHC expression of donors, or to differences in exposure of the graft site to the blood circulation, or to an immunological cross reaction between the environmental antigens and those of the graft (Mason et al. 1986) .
Normal brain has been reported to fail to express MHC antigens or else express them minimally (Wong et al. 1984; Lampson 1987 ). However, recent neuroimmunological studies have demonstrated that expression of Class I MHC antigens on both neurons and glial cells and expression of Class II MHC antigens on astrocytes can be induced in vitro by such lymphokines as gamma-interferon (Fierz et al. 1985; Wong et al. 1985) . Class II MHC antigen expression on endothelial cells and astrocytes obtained from patients with multiple sclerosis has also been detected (Traugott et al. 1985) , as has gliosis surrounding tumor metastases and abscesses (Frank et al. 1986 ). In brain tissue transplantation, Mason et al. (1986) detected expression of Class I MHC antigens on xenogeneic and allogeneic grafts during the course of rejection, in just the same way as occurs during rejection of other organ allografts (Milton and Fabre 1985; Pepose et al. 1985) . Thus, it is clear that although normal brain tissue lacks these antigens (Lampson 1987) , immunological stimuli can induce their expression (Mason et al. 1986 ). In the present study, we also detected expression of Class I MHC antigens on grafts, particularly around blood vessels, when rejection was occurring (Fig. 2B) . Increases in expression seemed to be correlated with the vigor of the host's immune response, an observation which is compatible with the claim that the level of Class I MHC antigen expression can serve as a semi-quantitative measure of the degree of host immune system activation (Mason et al. 1986 ). Our observation also suggested that Class II MHC antigens were expressed in grafts undergoing rejection, possibly on reactive astrocytes and endothelial cells (not shown in figures). However, further studies need to be performed before this can be clarified with certainty.
Recent in vitro studies indicated that astrocytes could produce or respond to a number of lym-21 phokines (Fontana 1982; Frei et al. 1986) , and that they presented foreign antigens to T cells (Fontana et al. 1984) . In addition to these reports, this study detected infiltration by T lymphocytes (Fig. 4) , a possible source of gamma-interferon, and a marked increase in reactive astrocytes in grafts undergoing rejection (Fig. 3D) . Thus reactive astrocytes may play a potent role in the immune response against MHC-incompatible allografts, and indeed it has been suggested that they are involved in some neuropathological conditions (Traugott et al. 1985; Frank et al. 1986 ).
In recipient animals bearing either syngeneic or MHC-compatible allogeneic grafts, we demonstrated by Thy-l.1 staining that the grafted fetal tissue matured in the adult brain. The Thy-1 antigen is known as a marker for differentiation of the nervous system, its levels in newborn mice being in the range of 1-2% of the mature brain, but increasing to adult levels within 4-5 weeks after birth (Reif 1984) . The Thy-1 molecule has two allelic forms, Thy-l.1 and Thy-l.2 (Reif and Allen 1966) . In this study it was possible to discriminate graft from host tissue using antibody against the Thy-l.1 allelic form (Fig. 1C) , and in fact this technique has been used to distinguish the two tissues by a number of investigators (Chadton et al. 1983; Zhou et al. 1985) .
It has been shown that T lymphocytes are able to recognize membrane-bound MHC antigens (Zinkernagel and Doherty 1979) , and recent investigations into allograft rejection have centered on the role of Class II-restricted helper/inducer (L3T4) T cells and Class I-restricted cytotoxic/suppressor (Lyt-2) T cells (Loveland and McKenZie 1982; LeFrancois and Bevan 1984) . Nicholas et al. (1987) recently identified in mice both T cell subsets in rejection responses against intraventricular neural allografts, and they found that L3T4-positive cells were generally more numerous than Lyt-2-positive cells in perivascular infiltrations. In our quantitative analysis of the two T cell subsets in single 0.25 mm 2 areas of sections from grafts undergoing rejection, however, no preponderance of either type could be detected. It is likely, therefore, that both of these T cell subsets are important effectors in rejection responses against MHC-incompatible allografts in the cerebellum.
The CNS parenchyma was reported immunologically more privileged than the ventricle for neural allografts (Murphy and Sturm 1923) , but our MHCincompatible allografts that had been implanted intraparenchymally underwent rejection. Although our results may not be automatically equated to other parenchymal sites in the brain, it is suggested that not only intraventricular allografts but also intraparenchymal ones are subject to rejection responses whose severity is related to the degree of genetic disparity between the donor and host.
